Endometriosis Assessment — ACOG 2026 Clinical Practice Guideline
Evidence-based endometriosis screening covering pelvic symptoms (dysmenorrhoea, chronic pelvic pain, dyspareunia), gastrointestinal symptoms (dyschezia, cyclical bowel changes), fertility concerns, TVUS imaging (ovarian endometriomas, pelvic masses, structural abnormalities), and pelvic MRI for deep infiltrating endometriosis (DIE).
Endometriosis Assessment
This assessment screens for endometriosis using the 2026 ACOG Clinical Practice Guideline, supported by ESHRE 2024 and ASRM 2022 guidelines. It evaluates symptoms across three clinical domains and integrates imaging findings for risk stratification.
ACOG 2026: Endometriosis is a clinical diagnosis supported by imaging. Definitive diagnosis requires laparoscopic histology, but evidence-based clinical assessment allows early identification and empirical treatment.
Pelvic Symptoms
Pain · Dysmenorrhoea · CPP
GI Symptoms
Dyschezia · Bowel changes
Imaging
TVUS · Pelvic MRI (DIE)
ACOG 2026 — Clinical Diagnosis Approach
Endometriosis can be diagnosed clinically when symptoms are classic. This assessment takes approximately 6–10 minutes. You may upload imaging reports for more accurate evaluation. All data is encrypted and clinically reviewed.